In the US, landmark initiatives such as the Orphan Drug Act (1983) 26 and the Accelerating Rare disease Cures program (2022) have promoted this mission by driving scientific innovation, regulatory flexibility and stakeholder engagement 27
By following these steps, healthcare providers can promote the safe and effective administration of B12 injections
cost and convenience favor oral once stable
Each COA documents identity by HPLC and/or mass spectrometry, purity, and, where applicable, sterility and endotoxin levels, plus lot-specific storage guidance
This would render oral formulations of DSIP virtually ineffective compared to nasal spray and injections [5]
Digital treatment modalities, such as mental health therapies and game-based interventions, offer the psychological support and engagement particularly suited to pediatric rare disease patients 44,45